A potpourri of partial ideas and topics for a peek inside what is on my mind.
Celiac disease is commonly found when a patient reports symptoms to their doctor. Simple blood tests are run. Most commonly the Tissue Transglutaminase IGA or TTG IGA test is done. The TTG IGA test often determines if further celiac testing is warranted. The reliance on the TTG IGA test to determine further celiac testing may be a bit overblown. I’ll explain.
here are a variety of clinical trials out there for those with celiac disease. Some are observational – where you just report to the researchers what you ate or how you felt. Some are investigational – where they are testing a new drug or treatment for celiac disease. Some require gluten ingestion, some don’t.
Eating plan for the first year being gluten free!
Refractory celiac disease or RCD is rarely diagnosed. Today’s study demonstrates why RCD is so rare. The study demonstrates that gluten exposure is often the culprit in ongoing celiac disease symptoms.
I have a gluten free diet that isn’t ideal, but effective to help with my celiac. So, the drug companies have to make a good argument to me that their drug will help alleviate symptoms and prevent damage to my intestines in order for me to spend my hard earned money on their solution. This begs the question – can someone prove to me that their drug works without a gluten challenge?